Vulnerability Details : CVE-2022-45611
An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.
Products affected by CVE-2022-45611
- cpe:2.3:o:fresenius-kabi:pharmahelp_firmware:5.1.759.0:*:*:*:*:*:*:*
Exploit prediction scoring system (EPSS) score for CVE-2022-45611
0.16%
Probability of exploitation activity in the next 30 days
EPSS Score History
~ 34 %
Percentile, the proportion of vulnerabilities that are scored at or less
CVSS scores for CVE-2022-45611
| Base Score | Base Severity | CVSS Vector | Exploitability Score | Impact Score | Score Source | First Seen |
|---|---|---|---|---|---|---|
|
9.8
|
CRITICAL | CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H |
3.9
|
5.9
|
NIST |
CWE ids for CVE-2022-45611
-
The product transmits or stores authentication credentials, but it uses an insecure method that is susceptible to unauthorized interception and/or retrieval.Assigned by: nvd@nist.gov (Primary)
References for CVE-2022-45611
-
https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf
-
https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder
PharmaHelp Compounder - Fresenius Kabi AustriaProduct
-
https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf
Jump to